Hyperspectral Imaging in Thoracic Surgery (PILOT-Tx-HSI)

June 3, 2022 updated by: LungenClinic Grosshansdorf

Pilot Study of Intraoperative Tissue Differentiation and Vascular Perfusion Using Intraoperative Hyperspectral Imaging (HSI) in Benign and Malignant Diseases of the Lung, Pleura and Mediastinum

The aim of this study is to find out whether hyperspectral imaging enables bronchus stump and bronchus anastomosis oxygenation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The bronchus before lung resection and the bronchus stump or bronchus anastomosis, respectively, are investigated. The hyperspectral imaging camera head is placed and aligned over the surgical (camera and object distance: 30 cm for all measurements). The Field of view is illuminated by 8 halogen spots (20 W each) and 100 wavelengths in the wavelength range from 500 to 1000 nm were applied. The software calculates the tissue oxygenation [%] , organ-hemoglobin-index, near-infrared-Index and the tissue-water-index of the investigated tissue. The study was designed to investigate tissue oxygenation in the superficial (app. 1mm) and deeper layers (app. 4-6mm) of the bronchus before and after lung resection.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Großhansdorf, Germany, 22927
        • LungenClinic Grosshansdorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • lung resection or other resection via thoracotomy

Exclusion Criteria:

  • Restriction of the ability to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: HSI-Pilot
Diagnostic hyperspectral imaging of the bronchus stump or bronchus anastomosis after lung resection and calculating the stump or anastomotic Perfusion measures, respectively
diagnostic hyperspectral imaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation: Bronchus before lung resection
Time Frame: directly before lung resection
Tissue perfusion of the bronchus before lung resection: Oxygenation (StO2) in %: Relative O2 saturation of the blood in superficial tissue layers (penetration depth: approx. 1 mm)
directly before lung resection
Oxygenation: Bronchus stump or bronchus anastomosis after lung resection
Time Frame: 10-15 minutes after lung resection
Tissue perfusion of the bronchus stump or bronchus anastomosis after lung resection: Oxygenation (StO2) in %: Relative O2 saturation of the blood the in superficial tissue layers (penetration depth: approx. 1 mm)
10-15 minutes after lung resection
Near Infrared Perfusion Index: Bronchus before lung resection
Time Frame: directly before lung resection
Tissue perfusion of the bronchus before lung resection: Near Infrared Perfusion Index: Tissue perfusion in deeper tissue layers (penetration depth: 4-6mm)
directly before lung resection
Near Infrared Perfusion Index: Bronchus stump or bronchus anastomosis after lung resection
Time Frame: 10-15 minutes after lung resection
Tissue perfusion of the bronchus stump or bronchus anastomosis after lung resection: Near Infrared Perfusion Index: Tissue perfusion in deeper tissue layers (penetration depth: 4-6mm)
10-15 minutes after lung resection
Tissue-Hemoglobin index: Bronchus before lung resection
Time Frame: directly before lung resection
Tissue perfusion of the bronchus before lung resection: Tissue-Hemoglobin index: Existing hemoglobin distribution in the tissue
directly before lung resection
Tissue-Hemoglobin index: Bronchus stump or bronchus anastomosis after lung resection
Time Frame: 10-15 minutes after lung resection
Tissue perfusion of the bronchus stump or bronchus anastomosis after lung resection: Tissue-Hemoglobin index: Existing hemoglobin distribution in the tissue
10-15 minutes after lung resection
Tissue-Water-Index: Bronchus before lung resection
Time Frame: directly before lung resection
Tissue perfusion of the bronchus before lung resection: Tissue-Water-Index: Existing water distribution in the tissue
directly before lung resection
Tissue-Water-Index: Bronchus stump or bronchus anastomosis after lung resection
Time Frame: 10-15 minutes after lung resection
Tissue perfusion of the bronchus stump or bronchus anastomosis after lung resection: Tissue-Water-Index: Existing water distribution in the tissue
10-15 minutes after lung resection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David B. Ellebrecht, MD, LungenClinic Grosshansdorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 21, 2021

Primary Completion (ACTUAL)

March 31, 2021

Study Completion (ACTUAL)

April 7, 2021

Study Registration Dates

First Submitted

February 25, 2021

First Submitted That Met QC Criteria

March 3, 2021

First Posted (ACTUAL)

March 5, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 6, 2022

Last Update Submitted That Met QC Criteria

June 3, 2022

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PILOT-Tx-HSI

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tissue Oxygenation

Clinical Trials on HSI

3
Subscribe